 | • レポートコード：QY20ST-06862 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の膣炎薬市場について種類別（Rx、OTC）、用途別（病院、薬局、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・膣炎薬市場の概要 ・世界の主要地域別膣炎薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の膣炎薬市場規模2015-2026：種類別（Rx、OTC） ・世界の膣炎薬市場規模2015-2026：用途別（病院、薬局、その他） ・膣炎薬の北米市場規模2015-2020 ・膣炎薬のヨーロッパ市場規模2015-2020 ・膣炎薬の中国市場規模2015-2020 ・膣炎薬の日本市場規模2015-2020 ・膣炎薬の東南アジア市場規模2015-2020 ・膣炎薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・膣炎薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・膣炎薬の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Vaginosis Drug Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Vaginosis Drug market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Vaginosis Drug market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Vaginosis Drug industry.
Based on our recent survey, we have several different scenarios about the Vaginosis Drug YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Vaginosis Drug will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Vaginosis Drug market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Vaginosis Drug market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Vaginosis Drug market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Vaginosis Drug market. The report also includes nautical information, where it shows Vaginosis Drug market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Vaginosis Drug market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Vaginosis Drug market.
Geographical Analysis:
Based on region, the global Vaginosis Drug market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Vaginosis Drug market are
Bayer
Pfizer
Sanofi
Piramal
Abbott
Galderma
Mission
Alkem
Xiuzheng
Teva
Perrigo
West-Ward
HPGC
Yunnan Baiyao
Starpharma
Novel
Edenvridge
Segment by Type
Rx
OTC
Segment by Application
Hospital
Pharmacy
Other
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Vaginosis Drug market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Vaginosis Drug market.
• The market share of the global Vaginosis Drug market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Vaginosis Drug market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Vaginosis Drug market.
1 Vaginosis Drug Market Overview
1.1 Vaginosis Drug Product Scope
1.2 Vaginosis Drug Segment by Type
1.2.1 Global Vaginosis Drug Sales by Type (2020-2026)
1.2.2 Rx
1.2.3 OTC
1.3 Vaginosis Drug Segment by Application
1.3.1 Global Vaginosis Drug Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Vaginosis Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Vaginosis Drug Sales Growth Rate (2015-2026)
1.4.2 Global Vaginosis Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Vaginosis Drug Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Vaginosis Drug Industry Impact
1.5.1 How the Covid-19 is Affecting the Vaginosis Drug Industry
1.5.1.1 Vaginosis Drug Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Vaginosis Drug Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Vaginosis Drug Players to Combat Covid-19 Impact
2 Vaginosis Drug Estimate and Forecast by Region
2.1 Global Vaginosis Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Vaginosis Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Vaginosis Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Vaginosis Drug Revenue Market Share by Region (2015-2020)
2.3 Global Vaginosis Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Vaginosis Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Vaginosis Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Vaginosis Drug Estimates and Projections (2015-2026)
2.4.2 Europe Vaginosis Drug Estimates and Projections (2015-2026)
2.4.3 China Vaginosis Drug Estimates and Projections (2015-2026)
2.4.4 Japan Vaginosis Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Vaginosis Drug Estimates and Projections (2015-2026)
2.4.6 India Vaginosis Drug Estimates and Projections (2015-2026)
3 Global Vaginosis Drug Competition Landscape by Players
3.1 Global Top Vaginosis Drug Players by Sales (2015-2020)
3.2 Global Top Vaginosis Drug Players by Revenue (2015-2020)
3.3 Global Vaginosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaginosis Drug as of 2019)
3.4 Global Vaginosis Drug Average Price by Company (2015-2020)
3.5 Manufacturers Vaginosis Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Vaginosis Drug Players (Opinion Leaders)
4 Global Vaginosis Drug Market Size by Type
4.1 Global Vaginosis Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Vaginosis Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Vaginosis Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Vaginosis Drug Price by Type (2014-2020)
4.2 Global Vaginosis Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Vaginosis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Vaginosis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Vaginosis Drug Price Forecast by Type (2021-2026)
5 Global Vaginosis Drug Market Size by Application
5.1 Global Vaginosis Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Vaginosis Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Vaginosis Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Vaginosis Drug Price by Application (2015-2020)
5.2 Global Vaginosis Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Vaginosis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Vaginosis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Vaginosis Drug Price Forecast by Application (2021-2026)
3 North America Vaginosis Drug Market Facts & Figures
3.2 North America Vaginosis Drug Sales Market Share by Company (2015-2020)
3.3 North America Vaginosis Drug Sales Market Share by Type (2015-2020)
3.4 North America Vaginosis Drug Sales Market Share by Application (2015-2020)
4 Europe Vaginosis Drug Market Facts & Figures
4.2 Europe Vaginosis Drug Sales Market Share by Company (2015-2020)
4.3 Europe Vaginosis Drug Sales Market Share by Type (2015-2020)
4.4 Europe Vaginosis Drug Sales Market Share by Application (2015-2020)
5 China Vaginosis Drug Market Facts & Figures
5.2 China Vaginosis Drug Sales Market Share by Company (2015-2020)
5.3 China Vaginosis Drug Sales Market Share by Type (2015-2020)
5.4 China Vaginosis Drug Sales Market Share by Application (2015-2020)
6 Japan Vaginosis Drug Market Facts & Figures
6.2 Japan Vaginosis Drug Sales Market Share by Company (2015-2020)
6.3 Japan Vaginosis Drug Sales Market Share by Type (2015-2020)
6.4 Japan Vaginosis Drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Vaginosis Drug Market Facts & Figures
7.2 Southeast Asia Vaginosis Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Vaginosis Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Vaginosis Drug Sales Market Share by Application (2015-2020)
8 India Vaginosis Drug Market Facts & Figures
8.2 India Vaginosis Drug Sales Market Share by Company (2015-2020)
8.3 India Vaginosis Drug Sales Market Share by Type (2015-2020)
8.4 India Vaginosis Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Vaginosis Drug Business
12.1 Bayer
12.1.1 Bayer Vaginosis Drug Corporation Information
12.1.2 Bayer Vaginosis Drug Business Overview and Total Revenue
12.1.3 Bayer Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer Vaginosis Drug Products Offered
12.1.5 Bayer Recent Development
12.2 Pfizer
12.2.1 Pfizer Vaginosis Drug Corporation Information
12.2.2 Pfizer Vaginosis Drug Business Overview and Total Revenue
12.2.3 Pfizer Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Vaginosis Drug Products Offered
12.2.5 Pfizer Recent Development
12.3 Sanofi
12.3.1 Sanofi Vaginosis Drug Corporation Information
12.3.2 Sanofi Vaginosis Drug Business Overview and Total Revenue
12.3.3 Sanofi Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sanofi Vaginosis Drug Products Offered
12.3.5 Sanofi Recent Development
12.4 Piramal
12.4.1 Piramal Vaginosis Drug Corporation Information
12.4.2 Piramal Vaginosis Drug Business Overview and Total Revenue
12.4.3 Piramal Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Piramal Vaginosis Drug Products Offered
12.4.5 Piramal Recent Development
12.5 Abbott
12.5.1 Abbott Vaginosis Drug Corporation Information
12.5.2 Abbott Vaginosis Drug Business Overview and Total Revenue
12.5.3 Abbott Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Abbott Vaginosis Drug Products Offered
12.5.5 Abbott Recent Development
12.6 Galderma
12.6.1 Galderma Vaginosis Drug Corporation Information
12.6.2 Galderma Vaginosis Drug Business Overview and Total Revenue
12.6.3 Galderma Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Galderma Vaginosis Drug Products Offered
12.6.5 Galderma Recent Development
12.7 Mission
12.7.1 Mission Vaginosis Drug Corporation Information
12.7.2 Mission Vaginosis Drug Business Overview and Total Revenue
12.7.3 Mission Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Mission Vaginosis Drug Products Offered
12.7.5 Mission Recent Development
12.8 Alkem
12.8.1 Alkem Vaginosis Drug Corporation Information
12.8.2 Alkem Vaginosis Drug Business Overview and Total Revenue
12.8.3 Alkem Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Alkem Vaginosis Drug Products Offered
12.8.5 Alkem Recent Development
12.9 Xiuzheng
12.9.1 Xiuzheng Vaginosis Drug Corporation Information
12.9.2 Xiuzheng Vaginosis Drug Business Overview and Total Revenue
12.9.3 Xiuzheng Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Xiuzheng Vaginosis Drug Products Offered
12.9.5 Xiuzheng Recent Development
12.10 Teva
12.10.1 Teva Vaginosis Drug Corporation Information
12.10.2 Teva Vaginosis Drug Business Overview and Total Revenue
12.10.3 Teva Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Teva Vaginosis Drug Products Offered
12.10.5 Teva Recent Development
12.11 Perrigo
12.11.1 Perrigo Vaginosis Drug Corporation Information
12.11.2 Perrigo Vaginosis Drug Business Overview and Total Revenue
12.11.3 Perrigo Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Perrigo Vaginosis Drug Products Offered
12.11.5 Perrigo Recent Development
12.12 West-Ward
12.12.1 West-Ward Vaginosis Drug Corporation Information
12.12.2 West-Ward Vaginosis Drug Business Overview and Total Revenue
12.12.3 West-Ward Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.12.4 West-Ward Vaginosis Drug Products Offered
12.12.5 West-Ward Recent Development
12.13 HPGC
12.13.1 HPGC Vaginosis Drug Corporation Information
12.13.2 HPGC Vaginosis Drug Business Overview and Total Revenue
12.13.3 HPGC Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.13.4 HPGC Vaginosis Drug Products Offered
12.13.5 HPGC Recent Development
12.14 Yunnan Baiyao
12.14.1 Yunnan Baiyao Vaginosis Drug Corporation Information
12.14.2 Yunnan Baiyao Vaginosis Drug Business Overview and Total Revenue
12.14.3 Yunnan Baiyao Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Yunnan Baiyao Vaginosis Drug Products Offered
12.14.5 Yunnan Baiyao Recent Development
12.15 Starpharma
12.15.1 Starpharma Vaginosis Drug Corporation Information
12.15.2 Starpharma Vaginosis Drug Business Overview and Total Revenue
12.15.3 Starpharma Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Starpharma Vaginosis Drug Products Offered
12.15.5 Starpharma Recent Development
12.16 Novel
12.16.1 Novel Vaginosis Drug Corporation Information
12.16.2 Novel Vaginosis Drug Business Overview and Total Revenue
12.16.3 Novel Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Novel Vaginosis Drug Products Offered
12.16.5 Novel Recent Development
12.17 Edenvridge
12.17.1 Edenvridge Vaginosis Drug Corporation Information
12.17.2 Edenvridge Vaginosis Drug Business Overview and Total Revenue
12.17.3 Edenvridge Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Edenvridge Vaginosis Drug Products Offered
12.17.5 Edenvridge Recent Development
13 Vaginosis Drug Manufacturing Cost Analysis
13.1 Vaginosis Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Vaginosis Drug
13.4 Vaginosis Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Vaginosis Drug Distributors List
14.3 Vaginosis Drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Vaginosis Drug Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global Vaginosis Drug Sales (K Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Vaginosis Drug Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Vaginosis Drug Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Vaginosis Drug Players to Combat Covid-19 Impact
Table 8. Global Market Vaginosis Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Vaginosis Drug Sales (K Doses) by Region (2015-2020)
Table 10. Global Vaginosis Drug Sales Market Share by Region (2015-2020)
Table 11. Global Vaginosis Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Vaginosis Drug Revenue Share by Region (2015-2020)
Table 13. Global Vaginosis Drug Sales (K Doses) Forecast by Region (2021-2026)
Table 14. Global Vaginosis Drug Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Vaginosis Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Vaginosis Drug Revenue Share Forecast by Region (2021-2026)
Table 17. Global Vaginosis Drug (K Doses) of Key Companies (2015-2020)
Table 18. Global Vaginosis Drug Sales Share by Company (2015-2020)
Table 19. Global Vaginosis Drug Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Vaginosis Drug Revenue Share by Company (2015-2020)
Table 21. Global Vaginosis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaginosis Drug as of 2019)
Table 22. Global Vaginosis Drug Average Price (USD/Dose) of Key Company (2015-2020)
Table 23. Manufacturers Vaginosis Drug Manufacturing Sites and Area Served
Table 24. Manufacturers Vaginosis Drug Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Vaginosis Drug Players
Table 27. Global Vaginosis Drug Sales (K Doses) by Type (2015-2020)
Table 28. Global Vaginosis Drug Sales Share by Type (2015-2020)
Table 29. Global Vaginosis Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Vaginosis Drug Price (K Doses) by Type (2015-2020)
Table 31. Global Vaginosis Drug Sales Share by Type (2021-2026)
Table 32. Global Vaginosis Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Vaginosis Drug Revenue Share by Type (2021-2026)
Table 34. Global Vaginosis Drug Price (K Doses) by Type (2021-2026)
Table 35. Global Vaginosis Drug Sales (K Doses) by Application (2015-2020)
Table 36. Global Vaginosis Drug Sales Share by Application (2015-2020)
Table 37. Global Vaginosis Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Vaginosis Drug Price (K Doses) by Application (2015-2020)
Table 39. Global Vaginosis Drug Sales (K Doses) by Application (2021-2026)
Table 40. Global Vaginosis Drug Sales Share by Application (2021-2026)
Table 41. Global Vaginosis Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Vaginosis Drug Revenue Share by Application (2021-2026)
Table 43. Global Vaginosis Drug Price (K Doses) by Application (2021-2026)
Table 44. United States Vaginosis Drug Sales (K Doses) by Company (2015-2020)
Table 45. United States Vaginosis Drug Sales Market Share by Company (2015-2020)
Table 46. United States Vaginosis Drug Sales (K Doses) by Type (2015-2020)
Table 47. United States Vaginosis Drug Sales Market Share by Type (2015-2020)
Table 48. United States Vaginosis Drug Sales (K Doses) by Application (2015-2020)
Table 49. United States Vaginosis Drug Sales Market Share by Application (2015-2020)
Table 50. Europe Vaginosis Drug Sales (K Doses) by Company (2015-2020)
Table 51. Europe Vaginosis Drug Sales Market Share by Company (2015-2020)
Table 52. Europe Vaginosis Drug Sales (K Doses) by Type (2015-2020)
Table 53. Europe Vaginosis Drug Sales Market Share by Type (2015-2020)
Table 54. Europe Vaginosis Drug Sales (K Doses) by Application (2015-2020)
Table 55. Europe Vaginosis Drug Sales Market Share by Type (2015-2020)
Table 56. China Vaginosis Drug Sales (K Doses) by Company (2015-2020)
Table 57. China Vaginosis Drug Sales Market Share by Company (2015-2020)
Table 58. China Vaginosis Drug Sales (K Doses) by Type (2015-2020)
Table 59. China Vaginosis Drug Sales Market Share by Type (2015-2020)
Table 60. China Vaginosis Drug Sales (K Doses) by Application (2015-2020)
Table 61. China Vaginosis Drug Sales Market Share by Application (2015-2020)
Table 62. Japan Vaginosis Drug Sales (K Doses) by Company (2015-2020)
Table 63. Japan Vaginosis Drug Sales Market Share by Company (2015-2020)
Table 64. Japan Vaginosis Drug Sales (K Doses) by Type (2015-2020)
Table 65. Japan Vaginosis Drug Sales Market Share by Type (2015-2020)
Table 66. Japan Vaginosis Drug Sales (K Doses) by Application (2015-2020)
Table 67. Japan Vaginosis Drug Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Vaginosis Drug Sales (K Doses) by Company (2015-2020)
Table 69. Southeast Asia Vaginosis Drug Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Vaginosis Drug Sales (K Doses) by Type (2015-2020)
Table 71. Southeast Asia Vaginosis Drug Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Vaginosis Drug Sales (K Doses) by Type (2015-2020)
Table 73. Southeast Asia Vaginosis Drug Sales Market Share by Application (2015-2020)
Table 74. India Vaginosis Drug Sales (K Doses) by Company (2015-2020)
Table 75. India Vaginosis Drug Sales Market Share by Company (2015-2020)
Table 76. India Vaginosis Drug Sales (K Doses) by Type (2015-2020)
Table 77. India Vaginosis Drug Sales Market Share by Type (2015-2020)
Table 78. India Vaginosis Drug Sales (K Doses) by Application (2015-2020)
Table 79. India Vaginosis Drug Sales Market Share by Application (2015-2020)
Table 80. Bayer Corporation Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Vaginosis Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Bayer Vaginosis Drug Product
Table 84. Bayer Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Vaginosis Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Pfizer Vaginosis Drug Product
Table 89. Pfizer Recent Development
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Vaginosis Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Sanofi Vaginosis Drug Product
Table 94. Sanofi Recent Development
Table 95. Piramal Corporation Information
Table 96. Piramal Description and Business Overview
Table 97. Piramal Vaginosis Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Piramal Vaginosis Drug Product
Table 99. Piramal Recent Development
Table 100. Abbott Corporation Information
Table 101. Abbott Description and Business Overview
Table 102. Abbott Vaginosis Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Abbott Vaginosis Drug Product
Table 104. Abbott Recent Development
Table 105. Galderma Corporation Information
Table 106. Galderma Description and Business Overview
Table 107. Galderma Vaginosis Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Galderma Vaginosis Drug Product
Table 109. Galderma Recent Development
Table 110. Mission Corporation Information
Table 111. Mission Description and Business Overview
Table 112. Mission Vaginosis Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Mission Vaginosis Drug Product
Table 114. Mission Recent Development
Table 115. Alkem Corporation Information
Table 116. Alkem Vaginosis Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Alkem Description and Business Overview
Table 118. Alkem Vaginosis Drug Product
Table 119. Alkem Recent Development
Table 120. Xiuzheng Corporation Information
Table 121. Xiuzheng Vaginosis Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 122. Xiuzheng Description and Business Overview
Table 123. Xiuzheng Vaginosis Drug Product
Table 124. Xiuzheng Recent Development
Table 125. Teva Corporation Information
Table 126. Teva Description and Business Overview
Table 127. Teva Vaginosis Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. Teva Vaginosis Drug Product
Table 129. Teva Recent Development
Table 130. Perrigo Corporation Information
Table 131. Perrigo Description and Business Overview
Table 132. Perrigo Vaginosis Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 133. Perrigo Vaginosis Drug Product
Table 134. Perrigo Recent Development
Table 135. West-Ward Corporation Information
Table 136. West-Ward Description and Business Overview
Table 137. West-Ward Vaginosis Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 138. West-Ward Vaginosis Drug Product
Table 139. West-Ward Recent Development
Table 140. HPGC Corporation Information
Table 141. HPGC Description and Business Overview
Table 142. HPGC Vaginosis Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 143. HPGC Vaginosis Drug Product
Table 144. HPGC Recent Development
Table 145. Yunnan Baiyao Corporation Information
Table 146. Yunnan Baiyao Description and Business Overview
Table 147. Yunnan Baiyao Vaginosis Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 148. Yunnan Baiyao Vaginosis Drug Product
Table 149. Yunnan Baiyao Recent Development
Table 150. Starpharma Corporation Information
Table 151. Starpharma Description and Business Overview
Table 152. Starpharma Vaginosis Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 153. Starpharma Vaginosis Drug Product
Table 154. Starpharma Recent Development
Table 155. Novel Corporation Information
Table 156. Novel Description and Business Overview
Table 157. Novel Vaginosis Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 158. Novel Vaginosis Drug Product
Table 159. Novel Recent Development
Table . Edenvridge Corporation Information
Table . Edenvridge Description and Business Overview
Table . Edenvridge Vaginosis Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table . Edenvridge Vaginosis Drug Product
Table . Edenvridge Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Vaginosis Drug Distributors List
Table 168. Vaginosis Drug Customers List
Table 169. Market Key Trends
Table 170. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 171. Key Challenges
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaginosis Drug Product Picture
Figure 2. Global Vaginosis Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Vaginosis Drug Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Pharmacy Examples
Figure 8. Other Examples
Figure 9. Global Vaginosis Drug Sales (K Doses) Growth Rate (2015-2026)
Figure 10. Global Vaginosis Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Vaginosis Drug Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 12. Global Vaginosis Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Vaginosis Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Vaginosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Vaginosis Drug Sales (K Doses) Growth Rate (2015-2026)
Figure 16. Europe Vaginosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Vaginosis Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Vaginosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Vaginosis Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Vaginosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Vaginosis Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Vaginosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Vaginosis Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Vaginosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Vaginosis Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Vaginosis Drug Players Market Share by Revenue in Vaginosis Drug 2015 & 2019
Figure 27. Vaginosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Vaginosis Drug Revenue Share by Type (2015-2020)
Figure 29. Global Vaginosis Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Vaginosis Drug Revenue Share by Application (2015-2020)
Figure 31. Global Vaginosis Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Vaginosis Drug Sales Market Share by Type in 2019
Figure 33. United States Vaginosis Drug Sales Market Share by Type in 2019
Figure 34. Europe Vaginosis Drug Sales Market Share by Company in 2019
Figure 35. Europe Vaginosis Drug Sales Market Share by Type in 2019
Figure 36. Europe Vaginosis Drug Sales Market Share by Application in 2019
Figure 37. China Vaginosis Drug Sales Market Share by Company in 2019
Figure 38. China Vaginosis Drug Sales Market Share by Type in 2019
Figure 39. China Vaginosis Drug Sales Market Share by Application in 2019
Figure 40. Japan Vaginosis Drug Sales Market Share by Company in 2019
Figure 41. Japan Vaginosis Drug Sales Market Share by Type in 2019
Figure 42. Japan Vaginosis Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Vaginosis Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Vaginosis Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Vaginosis Drug Sales Market Share by Application in 2019
Figure 46. India Vaginosis Drug Sales Market Share by Company in 2019
Figure 47. India Vaginosis Drug Sales Market Share by Type in 2019
Figure 48. India Vaginosis Drug Sales Market Share by Application in 2019
Figure 49. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Piramal Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Galderma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Mission Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Alkem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Xiuzheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Perrigo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. West-Ward Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. HPGC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Yunnan Baiyao Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Starpharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Novel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Edenvridge Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Key Raw Materials Price Trend
Figure 67. Manufacturing Cost Structure of Vaginosis Drug
Figure 68. Manufacturing Process Analysis of Vaginosis Drug
Figure 69. Vaginosis Drug Industrial Chain Analysis
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
Figure 72. Porter's Five Forces Analysis
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
予防的HIV薬の世界市場レポート2020 A recently published report by QY Research titled Global Prophylactic HIV Drug Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accur…- 抗エイズ薬の世界市場レポート2020 A recently published report by QY Research titled Global Anti-AIDs Drug Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate dat…
- 路上用薬物検査装置の世界市場レポート2020 A recently published report by QY Research titled Global Roadside Drug Testing Device Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provide…
- 誘発性前庭痛治療薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Provoked Vestibulodynia Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Provoked Vestibu…
- 光増感剤の世界市場レポート2020 Market Analysis and Insights: Global Photosensitizer Drug Market Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus diseas…